Medicine formula for treating prostatitis and benign prostatic hyperplasia and preparation process thereof
A technology for benign prostatic hyperplasia and prostatitis, which is applied in the field of medicine to achieve the effects of short course of treatment, guaranteed safety and less resistance to drug resistance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0022] A medicinal formula for treating prostatitis and benign prostatic hyperplasia, comprising the following components by weight, cefoperazone sodium sulbactam sodium 1000-8000mg, edetate disodium 2-40mg, dexamethasone 1-20mg, levobupivacaine 20-20mg 200mg, procaine 40 ~ 400mg.
[0023] Preparation:
[0024] (1) Dissolve cefoperazone sodium and sulbactam sodium with an appropriate amount of 0.9% sodium chloride solution for injection, and then dilute to 5-50ml with the same solution. After dissolving cefoperazone sodium, the molar concentration is 0.2mol / L. The concentration is 0.31mol / L
[0025] (2) Then dilute to 5-50ml with the same solution, the molar concentration after dissolving cefoperazone sodium is 0.2mol / L, and the molar concentration after dissolving sulbactam sodium is 0.31mol / L
[0026] Instructions:
[0027] The injection technology of avoiding nerves and blood vessels and inserting needles through the perineal and pelvic space allows the drug to fully pen...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com